EMA’s Conflict Of Interest Rules Must Not Limit Access To Experts And Risk Innovation, Warns Industry

The European Medicines Agency has published new policies on handling conflicts of interests for its scientific committee members, experts and management board members.

The EMA has published its updated CoI policy for committee members and experts (Shutterstock)

More from Europe

More from Agency Leadership